
Daiwik Pharmasphere Private Limited
Manufacturing and trading of dietary and health foods, supplements, and medicaments.
Manufacturing and trading of dietary and health foods, supplements, and medicaments.
Daiwik Pharmasphere Private Limited (DPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 December 2010 and has a history of 14 years and two months. Its registered office is in Navsari, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.30 Cr and a paid-up capital of Rs 1.19 Cr.
The company currently has active open charges totaling ₹7.80 Cr.
Apurva Bhayani, Rajesh Bhayani, Ajay Patel, and Five other members serve as directors at the Company.
Navsari, Gujarat, India
+91-XXXXXXXXXX
U24230GJ2010PTC063325
063325
Private Limited Indian Non-Government Company
22 Dec 2010
30 Sep 2023
31 Mar 2023
Unlisted
Roc Ahmedabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Apurva Bhayani ![]() | Director | 28-Jun-2017 | Current |
Rajesh Bhayani ![]() | Director | 22-Dec-2010 | Current |
Ajay Patel ![]() | Director | 22-Dec-2010 | Current |
Kalpesh Mehta ![]() | Director | 28-Jun-2017 | Current |
Neha Desai ![]() | Director | 11-Jul-2019 | Current |
Atit Patel ![]() | Director | 25-Feb-2015 | Current |
Daiwik Pharmasphere Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 82.47% increase. The company also saw a substantial improvement in profitability, with a 24.69% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.95%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Daiwik Pharmasphere had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Apurva Bhayani and Rajesh Bhayani are mutual person
Apurva Bhayani and Rajesh Bhayani are mutual person
Apurva Bhayani and Rajesh Bhayani are mutual person
Ajay Patel is a mutual person
Kalpesh Mehta and Sanjay Mehta are mutual person
Kalpesh Mehta and Sanjay Mehta are mutual person
₹7.80 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
29 Jun 2016 | Hdfc Bank Limited | ₹3.90 Cr | Open |
18 Jun 2016 | Hdfc Bank Limited | ₹3.90 Cr | Open |
Daiwik Pharmasphere has a workforce of 48 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Daiwik Pharmasphere, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daiwik Pharmasphere's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Daiwik Pharmasphere Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Daiwik Pharmasphere Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
A charge with Hdfc Bank Limited of Rs. 3.90 Cr registered on 18 Jun 2016 with Charge ID 100043178 was modified on 18 May 2022.
A charge with Hdfc Bank Limited of Rs. 3.90 Cr registered on 29 Jun 2016 with Charge ID 100037206 was modified on 27 Apr 2022.
Apurva Gunvantrai Bhayani was appointed as a Director was appointed as a Director on 28 Jun 2017 & has been associated with this company since 7 years 8 months .
Kalpesh Mahendra Mehta was appointed as a Director was appointed as a Director on 28 Jun 2017 & has been associated with this company since 7 years 8 months .
Daiwik Pharmasphere Private Limited was incorporated on 22 Dec 2010.
The authorized share capital of Daiwik Pharmasphere Private Limited is ₹ 1.30 Cr and paid-up capital is ₹ 1.19 Cr.
Currently 8 directors are associated with Daiwik Pharmasphere Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Daiwik Pharmasphere Private Limited is 17 Abvp Shopping Centre Opp-Parsi Hospital, India, Navsari, Gujarat, 396445.
The corporate identification number (CIN) of Daiwik Pharmasphere Private Limited is U24230GJ2010PTC063325 and the company number is 063325 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Daiwik Pharmasphere Private Limited has risen by 82.47%.
As Per 2023 financial reports, 48 employees are currently employed by Daiwik Pharmasphere Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Daiwik Pharmasphere Private Limited has experienced an downturn of -12.95%.
As per the financial statements for fiscal Year 2023, The total open charges for Daiwik Pharmasphere Private Limited amount to ₹ 7.80 Cr.
The most recent Balance Sheet for Daiwik Pharmasphere Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.